Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

ABSTRACT:

Background

Routine monitoring of cancer-related distress is recognized as essential to quality care and mandated by a major accrediting organization. However, to the authors' knowledge, few cancer-specific measures have been developed to date to assess the multiple cancer-related factors contributing to this distress. In the current study, the authors examined the psychometric properties of the Cancer and Treatment Distress (CTXD) measure over time in hematopoietic cell transplantation (HCT) recipients.

Methods

As a secondary analysis of a multicenter randomized controlled clinical trial, adult patients undergoing autologous or allogeneic HCT completed patient-reported outcomes including the CTXD and the Medical Outcomes Study Short Form-36 (SF-36) before transplantation and

SUBMITTER: Syrjala KL 

PROVIDER: S-EPMC5384862 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature